Latest Biotech News

Artificial intelligence and advanced technology are driving diverse innovations from AI-guided antibody discovery, precision cancer therapy via low-intensity ultrasound, to improved diagnostics...

Moderna’s seasonal influenza vaccine, mRNA-1010, succeeded in a large Phase 3 trial demonstrating a 26.6% relative efficacy advantage over standard-dose licensed flu vaccines in adults aged 50 and...

AbbVie has agreed to acquire Capstan Therapeutics in a deal worth up to $2.1 billion, securing access to a phase I in vivo CAR-T therapy targeting CD19 and proprietary lipid nanoparticle delivery...

INmune Bio's XPro, a TNF inhibitor targeting neuroinflammation in early Alzheimer’s disease, failed to meet primary and secondary endpoints in a 200-patient Phase 2 study, sending shares tumbling...

A novel study involving University of Pittsburgh and international collaborators shows that genetic ancestry alters immune responses in human skin explants infected with dengue virus. Findings...

Caltech researchers have introduced a photoacoustic computed tomography (PACT) method for breast cancer imaging that combines sound’s deep tissue penetration with light’s molecular sensitivity....

Following its recent acquisition announcement, Sage Therapeutics plans to lay off nearly all employees, with state filings detailing a reduction of 338 jobs effective August 22. This move follows...

Research from the Buck Institute reveals that glycogen accumulation in neurons exacerbates tauopathy diseases such as Alzheimer’s by impairing oxidative stress management. Restoration of glycogen...

Carnegie Mellon University researchers have demonstrated real-time, finger-level control of robotic hands using a noninvasive brain-computer interface (BCI). This milestone paves the way for...

Scientists at the Changchun Institute of Applied Chemistry have developed a targeted cancer treatment platform combining low-intensity ultrasound with therapeutic agents. This strategy enhances...

A collaborative study involving South Korean and US researchers utilized a comprehensive genetic testing workflow integrating whole-genome sequencing and functional analyses to diagnose over half...

AbbVie has agreed to acquire Capstan Therapeutics for up to $2.1 billion, expanding its pipeline into in vivo CAR-T therapies. Capstan, founded in 2022, develops CAR-T candidates targeting...

Pharma's once-promising TIGIT immuno-oncology target has collapsed after costly clinical failures, leading to billions lost. Key players including Bristol Myers Squibb, Gilead, GSK, and Novartis...

Recent advances in gene-editing technologies and regulatory approaches are enabling the development of therapies for ultrarare diseases affecting fewer than one in 50,000 people. A landmark case...

Following FDA approvals of monoclonal antibodies Leqembi and Kisunla for Alzheimer’s disease, dealmaking in the space has surged dramatically. GlobalData reports Alzheimer’s M&A deal values jumped...

Researchers at The Hebrew University of Jerusalem and partners have developed advanced drone systems integrating hyperspectral, thermal, and RGB sensors with AI algorithms to detect nitrogen and...

A University of Basel study published in Nature Communications reveals novel intracellular mechanisms restricting antisense oligonucleotide (ASO) therapies' effectiveness and identifies strategies...

Recent developments in oncology include Amgen’s FGFR2b-targeting antibody showing significant overall survival gains in a Phase 3 stomach cancer trial, albeit with ocular side effects raising...

Applied DNA Sciences has restructured to focus on synthetic DNA manufacturing by closing its clinical lab and cutting 27% of staff, aiming to reduce costs and scale nucleic acid therapy...

Innovative AI models developed by an OpenAI-backed startup have exhibited superior success in designing antibodies experimentally, outperforming existing protein modeling tools. Pfizer enhanced...